Afghanistan vs Togo: Previously treated cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Togo
100.0%
in 2024
Afghanistan rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Afghanistan
- Togo
How they compare
Afghanistan currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 7 times across 12 shared years of data; in 2012 it was Afghanistan ahead.
Afghanistan ranks 1st and Togo ranks 1st of 180 countries.
Togo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 45.5% | 64.1% | 18.7% | Togo |
| 2020s | 89.0% | 90.8% | 1.8% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Afghanistan or Togo?
- Afghanistan, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Afghanistan and Togo?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Togo?
- 12 years are reported by both, from 2012 to 2024.
- How do Afghanistan and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Togo ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.